The impact of radiological retroperitoneal lymphadenopathy on survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases

被引:3
作者
van der Werf, L. R. [1 ]
Wassenaar, E. [2 ]
de Niet, A. [1 ]
Lalezari, F. [3 ]
Braam, H. J. [4 ]
van Ramshorst, B. [2 ]
Nederend, J. [5 ]
de Hingh, I. H. J. T. [4 ]
Kok, N. F. M. [1 ]
Aalbers, A. G. J. [1 ]
机构
[1] Netherlands Canc Inst Antoni van Leeuwenhoek, Dept Surg Oncol, POB 90203, NL-1006 BE Amsterdam, Netherlands
[2] Antonius Hosp, Dept Surg Oncol, Nieuwegein, Netherlands
[3] Netherlands Canc Inst Antoni van Leeuwenhoek, Dept Radiol, Amsterdam, Netherlands
[4] Catharina Hosp, Dept Surg Oncol, Eindhoven, Netherlands
[5] Catharina Hosp, Dept Radiol, Eindhoven, Netherlands
来源
EJSO | 2019年 / 45卷 / 03期
关键词
Retroperitoneal lymphadenopathy; Hipec; peritoneal metastases; Retroperitoneal lymph nodes; CRS-HIPEC; SYSTEMIC CHEMOTHERAPY; RANDOMIZED-TRIAL; LYMPH-NODES; CARCINOMATOSIS; HIPEC; CANCER; MALIGNANCIES; CRITERIA; NOMOGRAM; ORIGIN;
D O I
10.1016/j.ejso.2018.10.540
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: To investigate the impact of retroperitoneal lymphadenopathy (RPLP) on pre-operative CT scan on overall survival (OS) and disease-free survival (DFS) after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) for peritoneal metastases (PM) of colorectal cancer. Background: In patients with PM enlarged retroperitoneal lymph nodes (RPLP) are usually considered extra-regional lymph node metastases and therefore these patients may be excluded from CRS-HIPEC. This is a clinical dilemma since it is often hard to obtain histology from these nodes. Methods: In this multicenter, retrospective study all consecutive patients with colorectal PM treated with CRS-HIPEC between 2004 and 2013 were included. The preoperative CT-scan was re-analyzed for the presence of RPLP based on the radiological appearance of enlarged lymph nodes. Outcomes were OS and DFS. Kaplan-Meier methods and Cox regression modeling were used to analyze the impact of RPLP on OS and DFS. Results: In 25 of 401 patients (6.1%) RPLP was observed on the preoperative CT-scan. Patient, tumor and surgical characteristics did not statistically significantly differ between groups with and without RPLP. After a median follow-up of 46 months, the one-, three- and five-year survival was 80%, 59%, 38% and 90%, 50%, 36% in the group with and without RPLP respectively. Median OS (47 vs. 35 months, logrank: p = 0.70) and median DFS (14 vs. 15 months, logrank: p = 0.81) did not statistically significantly differ between groups. In multivariable analysis, RPLP did not significantly influence survival. Conclusion: Enlarged retroperitoneal lymph nodes on a pre-operative CT-scan should not automatically exclude patients from CRS-HIPEC. (C) 2018 Elsevier Ltd, BASO similar to The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
引用
收藏
页码:376 / 382
页数:7
相关论文
共 20 条
[1]   Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases Systematic review of all literature and meta-analysis of observational studies [J].
de Cuba, E. M. V. ;
Kwakman, R. ;
Knol, D. L. ;
Bonjer, H. J. ;
Meijer, G. A. ;
te Velde, E. A. .
CANCER TREATMENT REVIEWS, 2013, 39 (04) :321-327
[2]   Quality-of-Life Evaluation After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy [J].
Dodson, Rebecca M. ;
McQuellon, Richard P. ;
Mogal, Harveshp D. ;
Duckworth, Katharine E. ;
Russell, Gregory B. ;
Votanopoulos, Konstantinos I. ;
Shen, Perry ;
Levine, Edward A. .
ANNALS OF SURGICAL ONCOLOGY, 2016, 23 :S772-S783
[3]   UPPER ABDOMINAL LYMPH-NODES - CRITERIA FOR NORMAL SIZE DETERMINED WITH CT [J].
DORFMAN, RE ;
ALPERN, MB ;
GROSS, BH ;
SANDLER, MA .
RADIOLOGY, 1991, 180 (02) :319-322
[4]   Modified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal origin [J].
Elias, D. ;
Mariani, A. ;
Cloutier, A. -S. ;
Blot, F. ;
Goere, D. ;
Dumont, F. ;
Honore, C. ;
Billard, V. ;
Dartigues, P. ;
Ducreux, M. .
EJSO, 2014, 40 (11) :1467-1473
[5]   A Simple Tumor Load-Based Nomogram for Surgery in Patients with Colorectal Liver and Peritoneal Metastases [J].
Elias, Dominique ;
Faron, Matthieu ;
Goere, Diane ;
Dumont, Frederic ;
Honore, Charles ;
Boige, Valerie ;
Malka, David ;
Ducreux, Michel .
ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (06) :2052-2058
[6]   Retroperitoneal nodal metastases from colorectal cancer: Curable metastases with radical retroperitoneal lymphadenectomy in selected patients [J].
Gagniere, J. ;
Dupre, A. ;
Chabaud, S. ;
Peyrat, P. ;
Meeus, P. ;
Rivoire, M. .
EJSO, 2015, 41 (06) :731-737
[7]   Operative Salvage for Retroperitoneal Nodal Recurrence in Colorectal Cancer: A Systematic Review [J].
Ho, Thomas WaiThong ;
Mack, Lloyd A. ;
Temple, Walley J. .
ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (03) :697-703
[8]   Implementation of a Standardized HIPEC Protocol Improves Outcome for Peritoneal Malignancy [J].
Kuijpers, Anke M. J. ;
Aalbers, Arend G. J. ;
Nienhuijs, Simon W. ;
de Hingh, Ignace H. J. T. ;
Wiezer, Marinus J. ;
van Ramshorst, Bert ;
van Ginkel, Robert J. ;
Havenga, Klaas ;
Heemsbergen, Wilma D. ;
Hauptmann, Michael ;
Verwaal, Victor J. .
WORLD JOURNAL OF SURGERY, 2015, 39 (02) :453-460
[9]   Cytoreduction and HIPEC in The Netherlands: Nationwide Long-term Outcome Following the Dutch Protocol [J].
Kuijpers, Anke M. J. ;
Mirck, Boj ;
Aalbers, Arend G. J. ;
Nienhuijs, Simon W. ;
de Hingh, Ignace H. J. T. ;
Wiezer, Martinus J. ;
van Ramshorst, Bert ;
van Ginkel, Robert J. ;
Havenga, Klaas ;
Bremers, Andreas J. ;
de Wilt, Johannes H. W. ;
te Velde, Elisabeth A. ;
Verwaal, Vic J. .
ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (13) :4224-4230
[10]   Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion - Analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique [J].
Kusamura, S ;
Younan, R ;
Baratti, D ;
Costanzo, P ;
Favaro, M ;
Gavazzi, C ;
Deraco, M .
CANCER, 2006, 106 (05) :1144-1153